Closing Bell Roundup

Activists Shake the Boardroom, Diagnostics Gain Momentum, and the FDA Slams the Brakes

Activists spark a surge, diagnostics beats guidance, and FDA setbacks crush biotech optimism.

Governance Loosens, Cancer Timelines Accelerate, and Dilution Hits Back

Governance flexibility sparks a surge, cancer data moves up fast, and dilution slams sellers.

Jets Get Faster Wi-Fi, Cancer Data Encourages, and Share Sales Sting

In-flight connectivity and cancer data spark rallies, while equity raises pressure on biotech.

Scale Slips Away, Governance Hardens, and Speed Takes the Lead

Psoriasis Breakthroughs Shine, AI Cars See Further, and Biotech Meets Some Hard Goodbyes

Biotech breakthroughs and LiDAR wins lift markets, even as CEO exits and drug setbacks hit others.

3D Printing Takes Flight, Dementia Data Delivers, and Biotech Meets a Tough Crowd